Drug profile · INN
bremelanotide acetate
VYLEESI (AUTOINJECTOR)
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
bremelanotide acetate (VYLEESI (AUTOINJECTOR)) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
Key facts
INN bremelanotide acetate
Brand VYLEESI (AUTOINJECTOR)
Route SUBCUTANEOUS
Formulation SOLUTION
Frequently asked questions
What is bremelanotide acetate?
bremelanotide acetate (VYLEESI (AUTOINJECTOR)) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
What is the brand name for bremelanotide acetate?
VYLEESI (AUTOINJECTOR) is a marketed brand name for bremelanotide acetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of bremelanotide acetate?
bremelanotide acetate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.